Caribou Biosciences (CRBU) Non-Current Deffered Revenue (2020 - 2026)
Caribou Biosciences (CRBU) recorded Non-Current Deffered Revenue of $1.42 million in Q2 2026, down 19.9% from $1.77 million a year earlier and down 13.8% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Non-Current Deffered Revenue of $1.75 million, down 47.2% from FY2024.
- Annual Non-Current Deffered Revenue has declined for four straight years, though with a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $3.32 million in FY2024 (-45.6%), $6.1 million in FY2023 (-61.8%), $15.95 million in FY2022 (-27.6%) and $22.03 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q4 2020.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for 12 consecutive quarters, with an average decline of 45.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 16.2% in Q2 2023, against a decline of 74.7% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.65 million (Q1 2026), $1.75 million (Q4 2025) and $1.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Caribou Biosciences | 129.31 Mn | -387.22 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 18.16 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 15.95 Mn |
| Sep 30, 2022 | 15.42 Mn |
| Jun 30, 2022 | 15.63 Mn |
| Mar 31, 2022 | 17.33 Mn |
| Dec 31, 2021 | 22.03 Mn |
| Sep 30, 2021 | 23.02 Mn |
API Access
Caribou Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();